Communicating Risk Information for Obesity
| Status: | Completed |
|---|---|
| Conditions: | Obesity Weight Loss |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 5/5/2014 |
| Start Date: | September 2011 |
| End Date: | November 2012 |
| Contact: | Lisa Wawak |
| Email: | lwawak@coriell.org |
| Phone: | 856-757-4845 |
Communicating Genetic Information for Obesity
This study will examine the impact of providing genetic risk information for obesity on
people's attitudes and beliefs about obesity, health behaviors and weight outcomes.
Specifically, this study will examine the feasibility of using genetic information to
motivate efforts to reduce obesity among individuals recruited to the Coriell Personalized
Medicine Collaborative (CPMC), see below for description of CPMC.
people's attitudes and beliefs about obesity, health behaviors and weight outcomes.
Specifically, this study will examine the feasibility of using genetic information to
motivate efforts to reduce obesity among individuals recruited to the Coriell Personalized
Medicine Collaborative (CPMC), see below for description of CPMC.
The investigators will conduct a randomized controlled feasibility trial to examine the
short-term impact of personalized risk feedback for obesity. This study is uniquely situated
to provide important data on how individuals interpret various sources of risk information
and how they arrive at an overall perception of risk for a condition. Taken altogether,
study findings will be used to serve as an overall model for future intervention efforts to
effectively communicate obesity risk information with the goal of improving weight
management and overall population health.
CPMC-The CPMC is an ongoing evidence-based longitudinal research study designed to determine
the utility of using personal genome information in health management and clinical
decision-making. They collect saliva samples, perform genetic analysis and provide genetic
risk feedback for several disease conditions including coronary artery disease and type 2
diabetes. The present study will build upon the existing genetic testing and web feedback
infrastructure at Coriell to conduct behavioral science research to address critical public
health questions.
short-term impact of personalized risk feedback for obesity. This study is uniquely situated
to provide important data on how individuals interpret various sources of risk information
and how they arrive at an overall perception of risk for a condition. Taken altogether,
study findings will be used to serve as an overall model for future intervention efforts to
effectively communicate obesity risk information with the goal of improving weight
management and overall population health.
CPMC-The CPMC is an ongoing evidence-based longitudinal research study designed to determine
the utility of using personal genome information in health management and clinical
decision-making. They collect saliva samples, perform genetic analysis and provide genetic
risk feedback for several disease conditions including coronary artery disease and type 2
diabetes. The present study will build upon the existing genetic testing and web feedback
infrastructure at Coriell to conduct behavioral science research to address critical public
health questions.
Inclusion Criteria:
Must be age 18 or older, active enrollees in the CPMC trial, and able to read and write in
English.
Exclusion Criteria:
Individuals that do not meet the inclusion criteria.
We found this trial at
1
site
Click here to add this to my saved trials
